The MPN Hub is an open-access online resource dedicated to providing balanced, credible, and up-to-date medical education on MPN, and is brought to you by Scientific Education Support (SES) in partnership with the European LeukemiaNet (ELN). The MPN Hub aims to enhance knowledge on MPN through disseminating advances related to its classification, diagnosis, treatment, and management via multiple channels.
February was a busy month for the MPN Hub with its presence in two congresses. During the 2021 Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR, held virtually on February 8–12, 2021, the MPN Hub provided live Twitter coverage of key sessions in the field of MPN and spoke to experts to seek answers to clinically relevant questions. More video interviews with experts were shared during the European School of Haematology (ESH) 2nd How to Diagnose and Treat CML / MPN meeting on February 25–28, 2021. In March, the 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), held virtually on March 14–17, 2021, was covered live on Twitter, and expert interviews and summaries of key sessions were published on the MPN Hub.
The MPN Hub would like to thank its founding industry partners Bristol Myers Squibb (Platinum), Novartis (Silver), Roche Genentech (Contributor), Kartos Therapeutics (Contributor), AOP Orphan (Contributor), Geron (Contributor), and Sierra Oncology (Contributor) for their continued support of the platform.
For more information on the MPN Hub, please visit mpn-hub.com.
For media enquiries or to explore opportunities for collaboration, please contact firstname.lastname@example.org.
Press release distributed by Pressat on behalf of Scientific Education Support, on Thursday 8 April, 2021. For more information subscribe and follow https://pressat.co.uk/